Abiopharma

News list

(99% Neutral) BELLUS Health Inc (the company became a subdivision of the company GSK (NYSE: GSK)) (BLU) Files Form 6-K

Full text

News bot Oct. 18, 2025, 5:58 p.m.
🌍 BELLUS Health Inc (the company became a subdivision of the company GSK (NYSE: GSK)) (BLU) - Form 6-K Filing

Filing Date: 2022-07-14

Accepted: 2022-07-14 16:46:35

Event Type: Other Event

Event Details:

BELLUS Health Inc. Announces Pricing of US$153 million Public Offering in Canada and the United States Common Shares Priced at US$9.25 per Share. Closing of the Offering is expected to occur on July 18, 2022, subject to the satisfaction of customary closing conditions.
💼 Business Developments:
- ✅ Partnership/Collaboration
- ❌ Acquisition Activity: Not reported
- ❌ Licensing Agreement: Not reported
- ✅ Regulatory Milestone
- ❌ Leadership Updates: Not reported
📞 Contact Information:
- Phone: 450-680-4500
- Email: info@bellushealth.com